- Home
- NAMS vs ITGR Comparison
NAMS vs ITGR Comparison
Compare NAMS & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | ITGR |
|---|---|---|
| Founded | 2019 | 1970 |
| Country | Netherlands | United States |
| Employees | 100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | NAMS | ITGR |
|---|---|---|
| Price | $30.89 | $97.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $46.75 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 977.5K | 430.5K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $17.96 | $1.69 |
| Revenue Next Year | $540.65 | $6.53 |
| P/E Ratio | ★ N/A | $201.17 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $21.14 | $62.00 |
| 52 Week High | $42.21 | $111.99 |
Technical Indicators
Market Signals| Indicator | NAMS | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 54.11 |
| Support Level | $29.23 | $88.32 |
| Resistance Level | $37.29 | $99.89 |
| Average True Range (ATR) | 1.96 | 2.85 |
| MACD | -0.43 | 0.08 |
| Stochastic Oscillator | 7.49 | 56.02 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.